Upstate Active Clinical Trials

Study Title:

Key Adverse Events Following Childhood Cancer

What is the purpose of the study?

Study to identify subjects who are more likely to develop late-occurring complications. Identified subjects are observed closely in order to prevent complications from occurring or to find complications early.

Upstate Institutional Review Board (IRB) Number:

264681

Study/Protocol ID:

ALTE03N1

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT00082745

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again